These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7667284)

  • 21. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
    Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
    J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of the human A-myb promoter: regulation by NF-Y and Sp1.
    Facchinetti V; Lopa R; Spreafico F; Bolognese F; Mantovani R; Tavner F; Watson R; Introna M; Golay J
    Oncogene; 2000 Aug; 19(34):3931-40. PubMed ID: 10951586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines.
    Schaefer BC; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10565-9. PubMed ID: 7479841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor.
    Raney AK; Le HB; McLachlan A
    J Virol; 1992 Dec; 66(12):6912-21. PubMed ID: 1331502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deletion of Epstein-Barr virus regulatory sequences upstream of the EBNA gene promoter Wp1 is unfavorable for B-Cell immortalization.
    Yoo LI; Woloszynek J; Templeton S; Speck SH
    J Virol; 2002 Nov; 76(22):11763-9. PubMed ID: 12388739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
    Sjöblom A; Nerstedt A; Jansson A; Rymo L
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator.
    Cohen JI; Kieff E
    J Virol; 1991 Nov; 65(11):5880-5. PubMed ID: 1656076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.
    Ling PD; Rawlins DR; Hayward SD
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9237-41. PubMed ID: 8415684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sp1 and AP2 regulate but do not constitute TATA-less human TAF(II)55 core promoter activity.
    Zhou T; Chiang CM
    Nucleic Acids Res; 2002 Oct; 30(19):4145-57. PubMed ID: 12364593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
    Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
    Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The adeno-associated virus type 2 p40 promoter requires a proximal Sp1 interaction and a p19 CArG-like element to facilitate Rep transactivation.
    Pereira DJ; Muzyczka N
    J Virol; 1997 Jun; 71(6):4300-9. PubMed ID: 9151818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
    J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterisation of regulatory sequences at the Epstein-Barr virus BamHI W promoter.
    Bell A; Skinner J; Kirby H; Rickinson A
    Virology; 1998 Dec; 252(1):149-61. PubMed ID: 9875325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene.
    Xia T; Zeng G; Gao L; Yu RK
    Gene; 2005 May; 351():109-18. PubMed ID: 15890474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two leaky-late HSV-1 promoters differ significantly in structural architecture.
    Lieu PT; Wagner EK
    Virology; 2000 Jun; 272(1):191-203. PubMed ID: 10873762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular transcription factors recruit viral replication proteins to activate the Epstein-Barr virus origin of lytic DNA replication, oriLyt.
    Baumann M; Feederle R; Kremmer E; Hammerschmidt W
    EMBO J; 1999 Nov; 18(21):6095-105. PubMed ID: 10545120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA.
    Bain M; Watson RJ; Farrell PJ; Allday MJ
    J Virol; 1996 Apr; 70(4):2481-9. PubMed ID: 8642676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroidogenic factor 1 (SF-1) and SP1 are required for regulation of bovine CYP11A gene expression in bovine luteal cells and adrenal Y1 cells.
    Liu Z; Simpson ER
    Mol Endocrinol; 1997 Feb; 11(2):127-37. PubMed ID: 9013760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element.
    Tan SH; Gloss B; Bernard HU
    Nucleic Acids Res; 1992 Jan; 20(2):251-6. PubMed ID: 1311070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.